Blumar
Blumar S.A. engages in the fishing and aquaculture businesses. The company produces and sells fresh or frozen salmon products in the United States, Brazil and the rest of Latin America, Europe, and Asia. It provides fishmeal and fish oil products used in the production of animal feed; and frozen mackerel. In addition, the company produces and sells mussels; and other products, such as fillets. It… Read more
Blumar (BLUMAR) - Total Liabilities
Latest total liabilities as of September 2025: CL$521.65 Million CLP
Based on the latest financial reports, Blumar (BLUMAR) has total liabilities worth CL$521.65 Million CLP as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Blumar - Total Liabilities Trend (2014–2024)
This chart illustrates how Blumar's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Blumar Competitors by Total Liabilities
The table below lists competitors of Blumar ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Costamare Bulkers Holdings Limited
NYSE:CMDB
|
USA | $309.79 Million |
|
Hefei Snowky Elec Co Ltd
SHE:001387
|
China | CN¥1.13 Billion |
|
Melar Acquisition Corp. I Class A Ordinary Shares
NASDAQ:MACI
|
USA | $10.89 Million |
|
Immobiliare Grande Distribuzione SIIQ S.p.A
PINK:IMMQF
|
USA | $859.08 Million |
|
McBride plc
PINK:MCBRF
|
USA | $398.94 Million |
|
Archer Ltd.
LSE:0RBA
|
UK | Nkr735.20 Million |
|
SimilarWeb Ltd
NYSE:SMWB
|
USA | $223.26 Million |
|
Tibet Weixinkang Medicine Co Ltd
SHG:603676
|
China | CN¥382.95 Million |
Liability Composition Analysis (2014–2024)
This chart breaks down Blumar's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.82 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Blumar's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Blumar (2014–2024)
The table below shows the annual total liabilities of Blumar from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CL$558.02 Million | +19.88% |
| 2023-12-31 | CL$465.47 Million | +2.62% |
| 2022-12-31 | CL$453.60 Million | -7.04% |
| 2021-12-31 | CL$487.97 Million | -7.94% |
| 2020-12-31 | CL$530.04 Million | +21.83% |
| 2019-12-31 | CL$435.05 Million | +56.73% |
| 2018-12-31 | CL$277.59 Million | +13.00% |
| 2017-12-31 | CL$245.66 Million | +5.32% |
| 2016-12-31 | CL$233.25 Million | -1.24% |
| 2015-12-31 | CL$236.18 Million | -9.28% |
| 2014-12-31 | CL$260.33 Million | -- |